AveXis, Inc.
Healthcare, Pharmaceuticals, and Biotech
Company Overview
Avexis Inc is a leading biotech company based in the United States, dedicated to developing innovative gene therapies for a range of debilitating neurological and genetic disorders. Founded in 2013, the company has built a strong reputation for pioneering research and development in the field of gene therapy, with a focus on rare diseases affecting infants and young children. Avexis has several products in its pipeline, including Zolgensma, a breakthrough treatment for spinal muscular atrophy approved by the FDA in 2019. Backed by an experienced team of scientists and researchers, and committed to improving patient outcomes through transformative therapies, Avexis has emerged as a leader in the biotech industry.
Email Formats
Discover the email patterns used at AveXis, Inc. to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
